Target intelligence / Profile preview

Transmembrane channel-like protein 1 (TMC1)

Target
TMC1
Molecular classification
Ion channel (mechanosensitive), Transmembrane protein
01

Overview

Transmembrane channel-like protein 1 is a mechanosensitive ion channel localized to cochlear hair cells, where it forms the ion-conducting pore of the mechanoelectrical transducer (MET) channel critical for sound detection. TMC1 assembles as a dimer with each subunit containing 10 transmembrane helices, forming a structure similar to TMEM16 and OSCA family channels. Mutations disrupting pore function reduce calcium permeability, trigger apoptosis of auditory hair cells, and lead to congenital or progressive hearing loss in humans and mice. TMC1 is mechanistically involved in the initial step of sensory transduction by gating in response to mechanical force delivered by tip links in hair cells, thus converting sound waves into electrical signals. Accessory proteins (e.g., TMIE, LHFPL5) help localize and regulate TMC1 at the stereocilia tips.

Other names
Transmembrane cochlear-expressed protein 1DFNA36DFNB7DFNB11transmembrane channel-like protein 1transmembrane, cochlear expressed, 1TMC1
02

Mechanism of action

For gene therapy: Restoration of TMC1 function in cochlear hair cells to recover auditory transduction. For mechanosensitive channel modulators: Hypothetical modulation of channel gating (not yet established drugs).

03

Biological functions

Mechanotransduction (conversion of mechanical force into electrical signals in hair cells)Auditory transduction(potentially) Vestibular transduction
04

Disease associations

Hereditary deafness (DFNA36, DFNB7/B11)Progressive hearing lossCongenital hearing lossHair cell apoptosis
05

Safety considerations

Potential off-target effects of gene therapySurgical risks for local delivery to the cochleaImpaired channel function (via mutation) leads to hair cell loss and deafness
06

Interacting drugs

TMC1 gene therapy
07

Biomarkers

TMC1 mutation status for diagnosis of genetic deafness syndromesAuditory function/responses in patients (clinical outcome)

Beyond the preview

Go deeper on Transmembrane channel-like protein 1 (TMC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane channel-like protein 1 (TMC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call